Boston Research & Management Inc Medtronic PLC Transaction History

Boston Research & Management Inc

  • $426 Million
  • Q3 2024

A detailed history of Boston Research & Management Inc transactions in Medtronic PLC stock. As of the latest transaction made, Boston Research & Management Inc holds 50,964 shares of MDT stock, worth $4.66 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares
50,964
Previous 48,487 5.11%
Holding current value
$4.66 Million
Previous $3.82 Million 20.23%
% of portfolio
1.08%
Previous 0.96%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$76.84 - $91.03 $190,332 - $225,481
2,477 Added 5.11%
50,964 $4.59 Million
Q2 2024

Aug 13, 2024
BUY
$78.71 - $87.02 $46,202 - $51,080
587 Added 1.23%
48,487 $3.82 Million
Q1 2024

May 14, 2024
BUY
$82.84 - $88.09 $66,603 - $70,824
804 Added 1.71%
47,900 $4.17 Million
Q4 2023

Feb 12, 2024
SELL
$69.43 - $83.43 $445,671 - $535,537
-6,419 Reduced 11.99%
47,096 $3.88 Million
Q3 2023

Nov 13, 2023
BUY
$78.22 - $90.4 $40,283 - $46,556
515 Added 0.97%
53,515 $4.19 Million
Q2 2023

Aug 01, 2023
BUY
$79.47 - $91.38 $42,913 - $49,345
540 Added 1.03%
53,000 $4.67 Million
Q1 2023

May 10, 2023
BUY
$76.72 - $87.58 $327,210 - $373,528
4,265 Added 8.85%
52,460 $4.23 Million
Q4 2022

Feb 13, 2023
SELL
$76.18 - $87.74 $214,446 - $246,988
-2,815 Reduced 5.52%
48,195 $3.75 Million
Q3 2022

Nov 14, 2022
BUY
$80.75 - $95.31 $286,662 - $338,350
3,550 Added 7.48%
51,010 $4.12 Million
Q2 2022

Aug 11, 2022
BUY
$87.4 - $113.09 $105,317 - $136,273
1,205 Added 2.61%
47,460 $4.26 Million
Q1 2022

May 12, 2022
BUY
$100.58 - $112.38 $128,440 - $143,509
1,277 Added 2.84%
46,255 $5.13 Million
Q4 2021

Feb 10, 2022
SELL
$99.53 - $127.75 $101,520 - $130,305
-1,020 Reduced 2.22%
44,978 $4.65 Million
Q3 2021

Nov 10, 2021
SELL
$122.75 - $135.17 $27,864 - $30,683
-227 Reduced 0.49%
45,998 $5.77 Million
Q3 2021

Nov 10, 2021
BUY
$122.75 - $135.17 $64,689 - $71,234
527 Added 1.15%
46,225 $5.46 Million
Q2 2021

Aug 11, 2021
SELL
$118.19 - $131.5 $62,286 - $69,300
-527 Reduced 1.14%
45,698 $5.67 Million
Q1 2021

May 11, 2021
BUY
$111.18 - $119.74 $209,574 - $225,709
1,885 Added 4.25%
46,225 $5.46 Million
Q4 2020

Feb 09, 2021
SELL
$100.57 - $117.14 $11,867 - $13,822
-118 Reduced 0.27%
44,340 $5.19 Million
Q3 2020

Nov 09, 2020
SELL
$90.13 - $108.78 $109,237 - $131,841
-1,212 Reduced 2.65%
44,458 $4.62 Million
Q2 2020

Aug 10, 2020
BUY
$84.11 - $103.33 $112,202 - $137,842
1,334 Added 3.01%
45,670 $4.19 Million
Q1 2020

May 08, 2020
SELL
$72.92 - $121.3 $20,417 - $33,964
-280 Reduced 0.63%
44,336 $4 Million
Q4 2019

Feb 07, 2020
SELL
$104.49 - $114.54 $6,791 - $7,445
-65 Reduced 0.15%
44,616 $5.06 Million
Q3 2019

Nov 12, 2019
SELL
$98.02 - $111.18 $22,544 - $25,571
-230 Reduced 0.51%
44,681 $4.85 Million
Q2 2019

Aug 07, 2019
BUY
$84.15 - $99.38 $60,167 - $71,056
715 Added 1.62%
44,911 $4.37 Million
Q1 2019

May 07, 2019
SELL
$82.45 - $93.79 $44,523 - $50,646
-540 Reduced 1.21%
44,196 $4.03 Million
Q4 2018

Feb 06, 2019
BUY
$85.8 - $99.49 $351,780 - $407,909
4,100 Added 10.09%
44,736 $4.07 Million
Q3 2018

Nov 13, 2018
SELL
$85.91 - $99.17 $36,941 - $42,643
-430 Reduced 1.05%
40,636 $4 Million
Q2 2018

Jul 30, 2018
BUY
$77.48 - $87.83 $80,579 - $91,343
1,040 Added 2.6%
41,066 $3.52 Million
Q1 2018

May 09, 2018
BUY
$76.55 - $87.26 $104,873 - $119,546
1,370 Added 3.54%
40,026 $3.21 Million
Q4 2017

Feb 09, 2018
SELL
$76.93 - $83.5 $31,156 - $33,817
-405 Reduced 1.04%
38,656 $3.12 Million
Q3 2017

Nov 09, 2017
BUY
$77.71 - $84.6 $3.04 Million - $3.3 Million
39,061
39,061 $3.04 Million

Others Institutions Holding MDT

# of Institutions
2,285
Shares Held
1.02B
Call Options Held
8.05M
Put Options Held
7.19M
View Full List

About Medtronic plc

MDT Quotes by TradingView
  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $121B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Boston Research & Management Inc Portfolio

Follow Boston Research & Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Research & Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Boston Research & Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email